Published in Vaccine Weekly, September 28th, 1998
Animal studies show that Chlamydia trachomatis antigens administered by the intranasal route elicit the kind of immunity known to protect against chlamydia infection and disease.
"Intranasal immunization is a potential delivery route of choice in the development of a vaccine against Chlamydia," concluded Joseph U. Igietseme of Morehouse School of Medicine, Atlanta, Georgia, and colleagues.
Igietseme et al. reported their findings in the journal Infection and Immunity ("Route of Infection that Induces a High Intensity of Gamma Interferon-Secreting T Cells in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1998-09-28)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.